ライフサイエンスコーパス: paraneoplastic syndrome

1 (18)F-FDG PET/CT in patients with suspected paraneoplastic syndrome.

2 malignancy in patients suspected of having a paraneoplastic syndrome.

3 n of the nervous system may be involved in a paraneoplastic syndrome.

4 (18)F-FDG PET/CT in patients with suspected paraneoplastic syndrome.

5 malignancy in patients suspected of having a paraneoplastic syndrome.

6 cally suspected neurologic and nonneurologic paraneoplastic syndromes.

7 ntly fatal malignancy and for the associated paraneoplastic syndromes.

8 oplasm in patients presenting with suspected paraneoplastic syndromes.

9 hare immunological features with spontaneous paraneoplastic syndromes.

10 e of clinical relevance for the treatment of paraneoplastic syndromes.

11 elevant pathways that lead to the associated paraneoplastic syndromes.

12 15 patients with cancer presented as classic paraneoplastic syndromes (5 limbic encephalitis, 1 paran

13 Paraneoplastic syndromes affecting the nervous system ar

14 ytotoxic CD8+ T cell in patients with the Hu paraneoplastic syndrome and suggest that SCLC may evade

15 93 individual patients suspected of having a paraneoplastic syndrome and who underwent (18)F-FDG PET

16 93 individual patients suspected of having a paraneoplastic syndrome and who underwent (18)F-FDG PET

17 stic neurological symptoms, 96 patients with paraneoplastic syndromes and 10 patients with non-cancer

18 nd toxic molecules to the internodal axon in paraneoplastic syndromes and demyelinating diseases.

19 "brain-testis-cancer" gene related to other paraneoplastic syndromes and tumors.

20 irect neurologic effects of lymphoma include paraneoplastic syndromes and vascular complications.

21 osition, after acute infection, as part of a paraneoplastic syndrome, and after exposure to neurotoxi

22 Paraneoplastic syndromes are not frequently associated w

23 Melanoma-associated retinopathy (MAR) is a paraneoplastic syndrome associated with cutaneous malign

24 of this review is to define and describe the paraneoplastic syndromes associated with gynecologic neo

25 icion of a paraneoplastic condition, but any paraneoplastic syndrome can also occur in patients witho

26 Some paraneoplastic syndromes can be used as marker of progre

27 ntagonist (VEGF-TRAP(R1R2)), thus defining a paraneoplastic syndrome caused by excessive VEGF activit

28 resistant, upbeat nystagmus resulting from a paraneoplastic syndrome caused by stage 2A, grade I, nod

29 ude, among others, vitiligo, thyroiditis and paraneoplastic syndromes, concurrent with melanoma, thyr

30 Twenty-four paraneoplastic syndromes have been associated with gynec

31 A wide range of organs can be affected in paraneoplastic syndromes; however, the pathological mech

32 Paraneoplastic syndromes (i.e. organ/tissue disorders as

33 on the possibility that scleroderma may be a paraneoplastic syndrome in a subset of patients.

34 rapeutic interventions for a group of visual paraneoplastic syndromes, including carcinoma-associated

35 Kidney cancer frequently causes paraneoplastic syndromes, including hypercalcemia and ca

36 a wide range of autoimmune, infectious, and paraneoplastic syndromes, making the differential diagno

37 Early diagnosis of paraneoplastic syndromes maximizes the likelihood of a f

38 on that their symptoms or findings reflect a paraneoplastic syndrome may allow the tumor responsible

39 systemic physiological perturbations, called paraneoplastic syndromes, may benefit from investigation

40 toantibodies or inflammatory gene mutations, paraneoplastic syndrome mechanisms via ectopic cytokine

41 fy the renal system as a central hub of this paraneoplastic syndrome model, wherein the pericardial n

42 Paraneoplastic syndromes occur in cancer patients and or

43 Paraneoplastic syndromes occurring before a cancer diagn

44 eration in normal tissues contributes to the paraneoplastic syndromes of cachexia and anemia.

45 109 small-cell lung cancer patients without paraneoplastic syndromes of the CNS.

46 Most nervous system paraneoplastic syndromes probably result from an immune

47 Paraneoplastic syndrome represents severe and complex sy

48 abnormalities is wide, and include cutaneous paraneoplastic syndromes such as xanthomas, acanthosis n

49 This tumor is associated with unique paraneoplastic syndromes, such as myasthenia gravis, hyp

50 proteins are associated with cancer-induced paraneoplastic syndromes that present with an autoimmune

51 is study, establishing a Drosophila model of paraneoplastic syndrome triggered by tumor transplantati

52 ple sclerosis, neuromyelitis optica, and the paraneoplastic syndromes where highly specific T cell re

53 POEMS syndrome is a paraneoplastic syndrome whose acronym stands for less th

54 Limbic encephalitis is typically a paraneoplastic syndrome with a poor prognosis; thus, ide

55 melanocytic proliferation (BDUMP) is a rare paraneoplastic syndrome with characteristic findings, in

56 Recent work has described paraneoplastic syndromes with prominent, and sometimes i